Top Institutions in Oncology Dermatology
Leading institutions conduct randomized clinical trials and systematic reviews focusing on dermatologic toxicities of chemotherapy, evaluating topical and systemic agents for HFS prevention, with expertise in oncology supportive care and dermatology.
-
#1
All India Institute of Medical Sciences
New Delhi, Delhi
Conducted pivotal systematic reviews and network meta-analyses on pharmacologic prevention of chemotherapy-induced HFS, with access to diverse patient populations and expertise in clinical trial methodology.
Key Differentiators
- Oncology
- Dermatology
- Clinical Research
-
#2
MD Anderson Cancer Center
Houston, Texas
Renowned for extensive clinical trials in oncology supportive care and management of chemotherapy toxicities, including cutaneous adverse effects like HFS.
Key Differentiators
- Oncology
- Dermatology
- Supportive Care
-
#3
Memorial Sloan Kettering Cancer Center
New York, New York
Expertise in translational research and clinical trials addressing chemotherapy-induced toxicities, with specialized dermatology services for cancer patients.
Key Differentiators
- Oncology
- Dermatology
- Clinical Trials
-
#4
Dana-Farber Cancer Institute
Boston, Massachusetts
Strong focus on pharmacologic interventions to mitigate chemotherapy side effects, with integrated oncology and dermatology research programs.
Key Differentiators
- Oncology
- Dermatology
- Pharmacology
-
#5
National Cancer Center Hospital
Tokyo, Tokyo
Leading institution in Asia with extensive clinical research on chemotherapy toxicities including HFS, contributing to regional data and clinical guidelines.
Key Differentiators
- Oncology
- Dermatology
- Clinical Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
